Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin aspart vs NovoRapid with insulin degludec in Chinese adults with type 1 or type 2 diabetes
CTR20201700Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Aug 2020; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20201700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201700.